We are a clinical stage biopharmaceutical company with a late-stage program in Alzheimer’s disease and a discovery platform of small molecules for the inhibition of protein misfolding and aggregation in neurodegenerative disorders.
$4.00 - $6.00
ThinkEquity A division of Fordham Financial Management, Inc., H.C. Wainwright & Co., The Benchmark Company
To view the prospectus for ALZHEON, INC. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277